Harbin Kuaihao Pharmaceutical

Harbin Kuaihao Pharmaceutical is a Chinese pharmaceutical company specializing in the development and manufacture of traditional Chinese medicine (TCM) injections and generic drugs. Established in 1994 and based in Harbin, the company operates advanced GMP-certified production facilities for large and small volume parenteral products. Its flagship products include Shenmai Injection and Xiangdan Injection, which are widely used in the domestic market for treating cardiovascular and respiratory conditions. The company focuses on the modernization of herbal medicine through standardized extraction and purification processes. Harbin Kuaihao Pharmaceutical plays a significant role in the regional healthcare sector of Northeast China, providing essential therapies for chronic and acute diseases.